In the U.S., FDA approval establishes Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) as the first immunotherapy combination approved for adult and pediatric patients 12 ...
SHANGHAI and HONG KONG, March 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ('Antengene', SEHK: 6996.HK) today ...
Henlius (2696.HK) today announced its annual results for the year ended December 31, 2025. During the reporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results